Roche
ROG.SW
$261.09
Share price
0.98%
Change (1 day)
-18.04%
Change (1 year)
Categories
Market capitalization of Roche (ROG.SW)
Market cap: $210.75 Billion
As of May 2024 Roche has a market cap of $210.75 Billion. This makes Roche the world's 55th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Roche from 2006 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $210.75 B | -9.95% |
| 2023 | $234.05 B | -9.83% |
| 2022 | $259.55 B | -27.83% |
| 2021 | $359.63 B | 20.2% |
| 2020 | $299.20 B | 8.27% |
| 2019 | $276.35 B | 31.2% |
| 2018 | $210.64 B | -1.97% |
| 2017 | $214.86 B | 9.77% |
| 2016 | $195.74 B | -17.9% |
| 2015 | $238.41 B | 2.92% |
| 2014 | $231.65 B | -2.73% |
| 2013 | $238.15 B | -24.51% |
| 2012 | $315.46 B | 114.14% |
| 2011 | $147.31 B | 15.59% |
| 2010 | $127.44 B | -14.38% |
| 2009 | $148.85 B | 9.99% |
| 2008 | $135.33 B | -10.67% |
| 2007 | $151.50 B | -1.96% |
| 2006 | $154.53 B |
End of Day market cap according to different sources
On May 18th, 2024 the market cap of Roche was reported to be:
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $372.16 B | 76.59% | 🇺🇸 USA |
 Novartis NVS | $209.58 B | -0.56% | 🇨🇭 Switzerland |
 Pfizer PFE | $162.29 B | -23.00% | 🇺🇸 USA |
 Abbott Laboratories ABT | $181.07 B | -14.08% | 🇺🇸 USA |
 Amgen AMGN | $167.61 B | -20.47% | 🇺🇸 USA |
 Sanofi SNY | $122.00 B | -42.11% | 🇫🇷 France |
 Becton Dickinson BDX | $68.29 B | -67.60% | 🇺🇸 USA |
 Merck MRK | $332.27 B | 57.66% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $94.75 B | -55.04% | 🇬🇧 UK |